Related Experiment Video
Updated: May 19, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Anti-cancer targeting telomerase inhibitors: β-rubromycin and oleic acid
Yoshiyuki Mizushina1, Toshifumi Takeuchi, Fumio Sugawara
1Laboratory of Food & Nutritional Sciences, Department of Nutritional Science, Kobe-Gakuin University, Kobe, Hyogo 651-2180, Japan. mizushin@nutr.kobegakuin.ac.jp
Abstract:
Telomerase is a ribonucleoprotein complex that elongates telomeric DNA and appears to play an important part in the cellular immortalization of cancers. In the screening of potent inhibitors of human telomerase, several inhibitors have been discovered from natural and chemical sources. Some compounds potently inhibit the activity of human telomerase. Rubromycins and fatty acids such as β-rubromycin and oleic acid, respectively, were found to be inhibitors of human telomerase. The IC(50) values of β-rubromycin and oleic acid were 8.60 and 8.78 μM, respectively. A kinetic study revealed that these compounds competitively inhibited the activity of telomerase with respect to the substrate of the primer and dNTP. The energy-minimized three-dimensional structure of β-rubromycin and oleic acid was calculated and designed. The V-shaped curve and molecule length of 18.7-20.3 Å in these compound structures were suggested to be important for telomerase inhibition. The three-dimensional structure of the active site of telomerase (i.e., the binding site of the primer and dNTP substrate) might have a "pocket" that could "join" these compounds. These results appear to suggest a potential structure for the development of more potent inhibitors of human telomerase.
Insights
Researchers identified β-rubromycin and oleic acid as potent inhibitors of human telomerase. Their V-shaped structure and molecular length are key for inhibiting telomerase activity, suggesting potential for new cancer drug development.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Telomerase is crucial for cancer cell immortalization.
- Identifying telomerase inhibitors is vital for cancer therapy.
- Natural and chemical compounds are screened for inhibitory activity.
Purpose of the Study:
- To screen for potent inhibitors of human telomerase.
- To investigate the inhibitory mechanism and structural features of identified compounds.
- To explore potential for developing novel telomerase inhibitors.
Main Methods:
- Screening of natural and chemical compounds for telomerase inhibition.
- Determination of IC(50) values for β-rubromycin and oleic acid.
- Kinetic analysis of enzyme inhibition.
- Energy-minimized 3D structure calculation and design.
Main Results:
- β-rubromycin and oleic acid demonstrated potent inhibition of human telomerase (IC(50) values of 8.60 and 8.78 μM).
- Inhibition was competitive with respect to primer and dNTP substrates.
- A V-shaped structure and molecular length of 18.7-20.3 Å were identified as important features for inhibition.
- A potential "pocket" in the telomerase active site may accommodate these inhibitors.
Conclusions:
- β-rubromycin and oleic acid are effective competitive inhibitors of human telomerase.
- Specific structural characteristics of these compounds are critical for their inhibitory function.
- These findings provide a basis for designing more potent telomerase inhibitors for cancer treatment.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Replicative Cell Senescence
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
